Tauroursodeoxycholic Acid
Evidence status
Limited evidence to recommend for any consumer outcome yet.
3 papers · 1 claim · 24 outcomes scored
Outcomes
What tauroursodeoxycholic acid actually does, by outcome
Each row is one outcome with effect size, evidence base, the dose that worked in trials, and time to first effect. Magnitude tiers come from native-unit MCID where available, Cohen's d otherwise.
Shrinks fat deposits in the liver and calms the inflammation driving disease forward.
| Outcome | Effect | Evidence | Dose | Weeks | Rank |
|---|---|---|---|---|---|
| Reverse fatty liver buildup Not enough research | | 1 RCT n=— | 1750 mg | 4 wk | — |
Sources
- 1. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. (2010) ↑
- 2. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. (2016) ↑
- 3. Administration of tauroursodeoxycholic acid prevents endothelial dysfunction caused by an oral glucose load. (2016) ↑
Generated August 14, 2026
Related
More evidence for Tauroursodeoxycholic Acid
Ingredient evidence
Ingredient evidence
NewBerberine
All scored outcomes
Aug 14, 2026
Ingredient evidence
Ingredient evidence
NewMilk Thistle
All scored outcomes
Aug 14, 2026
Ranking
Fatty Liver Disease
NewBest Supplements for Fatty Liver Disease (NAFLD), Ranked by Evidence
Evidence ranking
Apr 4, 2026
Systematic review
Systematic review
NewGreen Tea for Metabolic Health: A Systematic Evidence Review
GRADE evidence review
Apr 8, 2026
Systematic review
Systematic review
NewResveratrol for Metabolic and Cardiovascular Health: A Systematic Evidence Review
GRADE evidence review
Apr 8, 2026